The Directors of the American Board of Addiction Medicine (ABAM) and The ABAM Foundation have appointed Kevin B. Kunz, MD., MPH, FASAM as their new Executive Vice President (EVP). Kunz will replace James F. Callahan, D.P.A., who has held this role since 2008. Kunz practices addiction medicine in Kona, Hawaii, and is Assistant Clinical Professor in the Department of Psychiatry at the University of Hawaii School of Medicine. He is a diplomate of the American Board of Preventive Medicine, and the American Board of Addiction Medicine. He served as ABAM and ABAM Foundation President (2008 to 2011), and as Specialty Director (Preventive Medicine) (2008 to the present), a position he will vacate when assuming his EVP responsibilities on January 1, 2013.
Kunz will collaborate with the Directors to promote the training and certification of an expanding number of physicians in the diagnosis, treatment, and prevention of addictive disorders.
“Now that access to care and patient demand for care is increasing, we want to make sure that evidence-based addiction treatment is available to all who need it. And Dr. Kunz is uniquely qualified to lead us, given his years of dedicated practice specializing in addiction medicine,” said Jeffrey H. Samet, MD, MA, MPH, President of ABAM and The ABAM Foundation, and Professor of Medicine and Chief, General Internal Medicine Section, Boston University School of Medicine